The median analysis with splitting of the GBM patient cohort into two subgroups depending on the survival time showed no significant differences in the protein expression of ABCG2, CD44, CD95, ELF4, and Nestin, as demonstrated in Figure 3(b). This evidence concerns the gene FAS and glioblastoma.